ADIPOQ Gene Variants and Their Impact on Body Weight and Type 2 Diabetes
Author Information
Author(s): Niina Siitonen, Leena Pulkkinen, Jaana Lindström, Marjukka Kolehmainen, Johan G Eriksson, Mika Venojärvi, Pirjo Ilanne-Parikka, Sirkka Keinänen-Kiukaanniemi, Jaakko Tuomilehto, Matti Uusitupa
Primary Institution: University of Eastern Finland
Hypothesis
The study aims to investigate the association of ADIPOQ gene variations with body weight, serum adiponectin concentrations, and conversion to type 2 diabetes in overweight subjects with impaired glucose tolerance.
Conclusion
Genetic variation in the ADIPOQ locus contributes to differences in body size and serum adiponectin levels, and may influence the risk of developing type 2 diabetes.
Supporting Evidence
- Five ADIPOQ SNPs were significantly associated with baseline body weight.
- Carriers of the rs266729 G allele had higher baseline body weight compared to CC genotype.
- 184 of 507 subjects converted from IGT to T2DM during the follow-up.
- Lower serum adiponectin concentrations were associated with specific ADIPOQ SNPs.
- Genetic variation in ADIPOQ may influence metabolic and anthropometric characteristics related to T2DM.
Takeaway
This study found that certain genes can affect how much people weigh and their risk of getting diabetes, especially if they are overweight.
Methodology
Participants were randomly assigned to a lifestyle intervention or control group, and DNA was genotyped for ten ADIPOQ SNPs to analyze associations with body weight and serum adiponectin levels.
Limitations
The study's sample size is moderate for genetic association studies, and serum adiponectin levels were only measured in a subset of participants.
Participant Demographics
The study included 507 participants, with 166 men and 341 women, aged 55.33 years on average, and a BMI of 31.25 kg/m2.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website